论文部分内容阅读
近日,2014年中国药学会药学期刊优秀论文奖评选结果揭晓,我刊2011年第4期刊出的同济大学附属同济医院陆峥主任撰写的《失眠症的诊断和药物治疗现状》入选研究类论文优秀论文奖。失眠症是最常见的夜间睡眠障碍,作为一种原发或继发状态,它既是一种症状也是一种疾病。失眠可导致患者日间功能缺陷,显著降低生活质量,给个人和社会带来严重的负面影响。通常而言,目前,促睡眠药
Recently, 2014 Chinese Pharmaceutical Association Pharmaceutical Journal Outstanding Paper Award results announced, I published in 2011 No. 4 Tongji Hospital Tongji Hospital, published by director Lu Zheng “insomnia diagnosis and drug treatment status” selected research papers excellent Paper Award. Insomnia is the most common nocturnal sleep disorder, both as a symptom and as a disease, as a primary or secondary condition. Insomnia can lead to functional deficits in patients during the day, significantly reducing the quality of life, causing serious negative impact on individuals and society. In general, at present, sleep-promoting drugs